AIM ImmunoTech Inc.

AMEX: AIM · Real-Time Price · USD
2.47
0.11 (4.66%)
At close: Aug 19, 2025, 10:21 AM

AIM ImmunoTech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
170K 202K 141K 135K
Cost of Revenue
31K 42K 19.92M 850K
Gross Profit
139K 160K -19.78M -715K
Operating Income
-19.77M -31.92M -19.92M -18.84M
Interest Income
5.19M n/a 629K n/a
Pretax Income
-17.32M -28.96M -19.45M -19.13M
Net Income
-17.32M -28.96M -21.09M -21.51M
Selling & General & Admin
13.71M 21.14M 13.07M 8.67M
Research & Development
6.2M 10.93M 6.99M 7.67M
Other Expenses
n/a n/a 1.49M n/a
Operating Expenses
19.91M 32.08M 20.06M 16.34M
Interest Expense
585K n/a n/a 67K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
19.94M 32.12M 20.06M 17.19M
Income Tax Expense
n/a n/a 1.64M 2.39M
Shares Outstanding (Basic)
56.02M 48.59M 48.05M 47.34M
Shares Outstanding (Diluted)
56.02M 48.59M 48.05M 47.34M
EPS (Basic)
-0.31 -0.6 -0.44 -0.45
EPS (Diluted)
-0.31 -0.6 -0.44 -0.45
EBITDA
-16.49M -31.68M -19.87M -18.25M
EBIT
-16.73M -28.96M -19.92M -19.06M
Depreciation & Amortization
246K 238K -424K 805K